The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells
The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells
复制标题
从牛分枝杆菌BCG中提取的海藻糖二霉菌酸酯脂质体通过激活树突状细胞和CD8 T细胞诱导抗肿瘤免疫
DOI:
10.1007/s00262-021-02870-2
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Tahara H
中科院分区:
文献类型:
--
作者:
Shiga Masanobu;Miyazaki Jun;Tanuma Kozaburo;Nagumo Yoshiyuki;Yoshino Takayuki;Kandori Shuya;Negoro Hiromitsu;Kojima Takahiro;Tanaka Ryota;Okiyama Naoko;Fujisawa Yasuhiro;Watanabe Miyuki;Yamasaki Sho;Kiyohara Hideyasu;Watanabe Makoto;Sato Taka-aki;Tahara H
IntravesicalBovis bacillusCalmette-Guérin (BCG) therapy is the most effective immunotherapy for bladder cancer, but it sometime causes serious side effects because of its inclusion of live bacteria. It is necessary to develop a more active but less toxic immunotherapeutic agent. Trehalose 6,6′-dimycolate (TDM), the most abundant hydrophobic glycolipid of the BCG cell wall, has been reported to show various immunostimulatory activities such as granulomagenesis and adjuvant activity. Here, we developed cationic liposomes incorporating TDM purified fromMycobacterium bovisBCG Connaught, and we investigated the antitumor effect of the cationic liposome TDM (Lip-TDM). Lip-TDM exerted an antitumor effect in bladder cancer, colon cancer, and melanoma-bearing mouse models that was comparable or even superior to that of BCG, with no body weight loss or granuloma formation. The antitumor effect of Lip-TDM disappeared in two types of mice: those with depletion of CD8+T cells, and those with knockout of macrophage-inducible C-type lectin (Mincle) which recognize TDM. Lip-TDM treatment enhanced the maturation and migration of dendritic cells in the tumor microenvironment in a Mincle-dependent manner. Our results elucidate mechanisms that underlie Lip-TDM treatment and suggest that Lip-TDM has potential as a safe and effective treatment for various cancers.
登录
查看更多内容
影响因子:
3.1
作者:
BEKIERKUNST, A;YARKONI, E
通讯作者:
YARKONI, E
影响因子:
3.1
作者:
E. Yarkoni;M. Goren;H. Rapp
通讯作者:
H. Rapp
影响因子:
50.3
作者:
Roberts EW;Broz ML;Binnewies M;Headley MB;Nelson AE;Wolf DM;Kaisho T;Bogunovic D;Bhardwaj N;Krummel MF
通讯作者:
Krummel MF
影响因子:
5.5
作者:
T. Sakurai;I. Saiki;H. Ishida;K. Takeda*;I. Azuma
通讯作者:
I. Azuma
DOI:
10.1007/bf01742373
发表时间:
2005
期刊:
Cancer Immunology, Immunotherapy
影响因子:
--
作者:
Y. Natsuhara;S. Oka;K. Kaneda;Y. Kato;I. Yano
通讯作者:
I. Yano